Chinese healthcare-focused GP HighLight Capital has reached the first close of $300 million on its third US dollar-denominated fund, but further progress is likely to be delayed by the coronavirus outbreak.
Amber Group, a Hong Kong-based start-up offering crypto-based financial services, has raised $28 million in a Series A round led by Paradigm and Pantera Capital.
SpaceX-inspired global fervor about the possibilities of space technology has infiltrated China. Some start-ups appear well set for commercial lift-off, but many others will misfire
China's CICC Capital has raised RMB1.6 billion ($229 million) for its first fund dedicated to the biopharmaceutical space.
Linctex Digital, a Shanghai-based design services platform for the fashion industry, has raised RMB100 million ($14 million) in funding led by Gaorong Capital. Shunwei Capital, Vision Plus Capital, Baidu Ventures and Yinxinggu Capital also took part.
Golden Goose, an Italian luxury footwear brand acquired three years ago by The Carlyle Group’s Europe and Asia funds, has been sold to Permira for around EUR1.3 billion ($1.4 billion).
Huize Holding, a Shanghai-based insurance platform backed by SAIF Partners, has raised about $55 million in a US IPO.
Hamilton Lane has led a $200 million restructuring of a VC fund managed by China-based Legend Capital, transferring 12 investments into a new vehicle as a means of extending the holding period.
Yijiupi, a Chinese B2B e-commerce platform that initially focused on liquor products, has acquired local B2B consumer goods distributor Zskuaixiao. It has also secured a new round of funding backed by several Zskuaixiao investors.
Cross-border technology investor 1955 Capital has emerged victorious in a legal battle with its Chinese anchor LP after a US court upheld an earlier arbitration ruling that the LP had no grounds for withdrawing from the fund.
Shanghai-based Universal Medical Imaging, China’s largest independent imaging diagnosis company has raised a RMB600 million ($86 million) Series B round led by Cathay Capital, V Star Capital and CEC Capital.
Having assessed some 40 autonomous driving companies globally, Lightspeed China Partners decided that Hesai - a business born in the US and raised in China - is best-placed to take the technology forwards
Manulife Investment Management is easing into its first Asian private markets drive with a focus on optionality. Private credit, infrastructure, and real estate are early areas of interest
Chinese biotech player Akeso Biopharma has made a second attempt at filing for a Hong Kong IPO after its previous application was rejected last month for failing to meet regulatory requirements.
Private equity firms in Asia are paying more attention to recruitment at the portfolio level, in some cases allocating dedicated in-house resources. How is it impacting attitudes towards leadership change?
CBC Group established biosimilars specialist AffaMed Therapeutics to remove uncertainties in the development process and to tap Chinese demand for affordable treatments
Joy Capital has announced its participation - as the lead investor - in an $88.3m funding round for Chinese community group buying platform Shihuituan, which is also known as Nice Tuan.
Chinese genetic testing specialist Genskey raised an RMB50 million ($7.1m) extended Series B round of funding led by Shenzhen-based Fortune Capital. Existing investor Legend Capital re-upped.
Japan’s TDK Corporation has made a VC commitment of undisclosed size in AutoFlightX, an electric air mobility company based in Germany with a significant China presence.
Hong Kong-based multi-family office Raffles Family Office will invest $15 million in local co-working space operator WorkTech.
China-focused Centurium Capital has enjoyed a productive 12 months, closing its debut US dollar fund, deploying most of the capital, and securing an early liquidity event
China would suffer the most immediate impact of a technology decoupling with the US, but both sides would be damaged in the long-term in the absence of remedial action
CITIC Capital has launched a special purpose acquisition vehicle (SPAC) – or blank check company – on the New York Stock Exchange to pursue deals under its One Belt One Road (OBOR) strategy.
Yunxuetang, an online corporate training services provider focused on China, has raised $100 million in Series D funding led by Centurium Capital. Existing investors Yunfeng Capital and SIG both re-upped.